logo

Perpetua Resources Publishes 2024 Sustainability Report

Cision Canada26-06-2025
BOISE, Idaho, June 26, 2025 /CNW/ - Perpetua Resources Corp. (Nasdaq: PPTA) (TSX: PPTA) ("Perpetua Resources" or "Perpetua" or the "Company") released its 2024 Sustainability Report highlighting the Company's key achievements and progress in advancing its environmental, social and governance ("ESG") goals. The report, which is the Company's 12th annual sustainability report, provides disclosure of ESG topics and aligns with the Sustainability Accounting Standards Board ("SASB") reporting framework for the Metals and Mining Industry.
"This year's sustainability report chronicles a period of significant progress for the Company, guided by our dedication to responsible stewardship and investment in the region we're proud to call home," said Jon Cherry, Perpetua Resources President and CEO. "A highlight of this past year was receiving our Final Environmental Impact Statement ("FEIS") and a Draft Record of Decision ("ROD") in September 2024, followed by receipt of a Final ROD in January 2025. These achievements propel us ever closer to bringing this important project online, allowing us to secure critical minerals for America's national security and provide much-needed environmental reclamation to the historical Stibnite Mining District."
2024 Sustainability Report Highlights:
154 months (12+ years) with no reportable spills
109 months with no lost time incidents
100 percent of employees participated in business integrity and compliance related training
Spent $19 million in legacy cleanup activities to improve water quality at site since 2021
Team members spent 1,204 hours serving the community
Spent $23.6 million in Idaho in 2024; more than $132 million since 2014
Perpetua Resources' 2024 Sustainability Report provides an in-depth look at the Company's sustainability achievements over the last year, as well as the Company's efforts to provide the U.S. with a domestic source of the critical mineral antimony, develop one of the largest and highest-grade open pit gold mines in the country, and restore an abandoned brownfield site.
About Perpetua Resources and the Stibnite Gold Project
Perpetua Resources Corp., through its wholly owned subsidiaries, is focused on the exploration, site restoration and redevelopment of gold-antimony-silver deposits in the Stibnite-Yellow Pine district of central Idaho that are encompassed by the Stibnite Gold Project. The Stibnite Gold Project is one of the highest-grade, open pit gold deposits in the United States and is designed to apply a modern, responsible mining approach to restore an abandoned mine site and produce both gold and the only mined source of antimony in the United States. Antimony trisulfide from Stibnite is the only known domestic reserves of antimony that can meet U.S. defense needs for many small arms, munitions, and missile types.
FORWARD-LOOKING INFORMATION
Statements contained in this news release that are not historical facts are "forward-looking information" or "forward-looking statements" (collectively, "Forward-Looking Information") within the meaning of applicable Canadian securities legislation and the United States Private Securities Litigation Reform Act of 1995. Forward-Looking Information includes, but is not limited to, disclosure regarding expected benefits from the Project, including providing a domestic source of antimony, national defense benefits and environmental benefits. In certain cases, Forward-Looking Information can be identified by the use of words and phrases or variations of such words and phrases or statements such as "anticipate", "expect", "plan", "likely", "believe", "intend", "forecast", "project", "estimate", "potential", "could", "may", "will", "would" or "should".. Forward-Looking Information in this news release are based on certain material assumptions and involve, known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of Perpetua Resources to be materially different from any future results, performance or achievements expressed or implied by the Forward-Looking Information. Such risks and other factors include those factors discussed in Perpetua Resources' public filings with the U.S. Securities and Exchange Commission (the "SEC") and its Canadian disclosure record. Although Perpetua Resources has attempted to identify important factors that could affect Perpetua Resources and may cause actual actions, events or results to differ materially from those described in Forward-Looking Information, there may be other factors that cause actions, events or results not to be as anticipated, estimated or intended. There can be no assurance that Forward-Looking Information will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on Forward-Looking Information. For further information on these and other risks and uncertainties that may affect the Company's business, see the "Risk Factors" and "Management's Discussion and Analysis of Financial Condition and Results of Operations" sections of the Company's filings with the SEC, including Perpetua's Annual Report on Form 10-K filed with the SEC on March 19, 2025, which are available at www.sec.gov and with the Canadian securities regulators, which are available at www.sedarplus.com. Except as required by law, Perpetua Resources does not assume any obligation to release publicly any revisions to Forward-Looking Information contained in this news release to reflect events or circumstances after the date hereof or to reflect the occurrence of unanticipated events.
SOURCE Perpetua Resources Corp.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Why CoreWeave Stock Skyrocketed Last Week
Why CoreWeave Stock Skyrocketed Last Week

Globe and Mail

time2 hours ago

  • Globe and Mail

Why CoreWeave Stock Skyrocketed Last Week

Key Points CoreWeave stock saw big gains in connection with news that its buyout of Core Scientific could be blocked. CoreWeave has entered into terms to buy Core Scientific in a $9 billion all-stock deal. Shareholders of both companies have some reservations about the acquisition deal. 10 stocks we like better than CoreWeave › CoreWeave (NASDAQ: CRWV) stock recorded huge gains over the past week of trading. The artificial intelligence (AI) company's share price soared 24.4% higher across the stretch. CoreWeave's big stock rally arrived in conjunction with the news that one of the company's big strategic initiatives could face major hurdles. According to reports, CoreWeave's $9 billion deal to buy Core Scientific could wind up being blocked -- but many investors actually seem to be happy with the news. What's next for CoreWeave? CoreWeave announced on July 7 that it had entered into an agreement to purchase Core Scientific at a $9 billion valuation. Even before the deal was officially announced, rumblings of a potential acquisition were met with negative reactions from CoreWeave shareholders. Some big Core Scientific shareholders are also apparently unhappy with the deal. While terms for the potential buyout have already been agreed to, Core Scientific's shareholders still need to approve the acquisition. Along with bullish valuation momentum for the broader AI space, hopes that the buyout could be scuttled helped power big gains for CoreWeave stock this week. What's next for CoreWeave? If CoreWeave were to complete its acquisition of Core Scientific, it would help the company reduce roughly $10 billion in lease expenses. On the other hand, the all-stock deal would result in a substantial amount of share value dilution for current stockholders -- and some investors and analysts are wondering whether the buyout is in the company's best interest. While news about the potential Core Scientific acquisition will probably continue to play a significant role in CoreWeave stock's near-term performance outlook, the AI cloud computing company has strengths that could allow it to deliver strong returns regardless of how the buyout situation resolves. Should you invest $1,000 in CoreWeave right now? Before you buy stock in CoreWeave, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and CoreWeave wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years. Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $653,427!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $1,119,863!* Now, it's worth noting Stock Advisor's total average return is 1,060% — a market-crushing outperformance compared to 182% for the S&P 500. Don't miss out on the latest top 10 list, available when you join Stock Advisor. See the 10 stocks » *Stock Advisor returns as of August 4, 2025

JBO Vietnam Announces Exclusive 2026 FIFA World Cup Bonuses - Up to 16.8M VND
JBO Vietnam Announces Exclusive 2026 FIFA World Cup Bonuses - Up to 16.8M VND

Cision Canada

time3 hours ago

  • Cision Canada

JBO Vietnam Announces Exclusive 2026 FIFA World Cup Bonuses - Up to 16.8M VND

, Aug. 11, 2025 /CNW/ -- With excitement growing for the 2026 FIFA World Cup, JBO Vietnam is proud to launch a limited-time promotion to make football more fun for fans across the country. This exclusive offer rewards both loyal players and new members, making every qualifying match more rewarding. JBO World Cup qualifiers promotion is available to all registered JBO Vietnam members who have selected Vietnamese Dong (VND) as their preferred currency. This special JBO promotion runs until 12 November 2025 and covers all 2026 World Cup qualifying matches, giving fans a chance to enjoy the action and earn great bonuses. Eligible users can participate through Inplay Matrix Sports, SABA Sports, and BTI Sports, stand a chance to earn up to 16,888,000 VND in bonus rewards based on your total accumulated betting turnover. Bonus credits will be issued by 22:59 (GMT+7) on the day following the end of each promotional phase. In addition, newly registered users are eligible for an exclusive welcome bonus of up to 5,000,000 VND, providing a valuable boost as they begin their World Cup journey with JBO. At JBO Vietnam, player safety is the highest priority. The platform uses strong security measures to keep all personal and financial information safe. With 24/7 customer support, players can get help anytime they need. With fast withdrawals and smooth gameplay, JBO is a great place for sports fans to enjoy matches and win real money. JBO proudly partners with football legend Dimitar Berbatov as its brand ambassador, strengthening its position as one of the top sportsbook platforms in Asia. The road to the 2026 World Cup is well underway. Register with JBO Vietnam today or download the JBO app to access exclusive promotions and be part of the action. About JBO Vietnam JBO (Just Bet Online) is a trusted online entertainment platform launched in 2019, serving players across Vietnam. It offers a wide variety of options, including sports, esports, slots, fishing games, and live casino experiences. With real-time action and high-quality gameplay, JBO continues to be a leading choice for sports fans, esports enthusiasts, and online gaming lovers in Vietnam.

Shionogi Eyes US Plant to Boost Antibiotic Production Amid Tariffs Challenge
Shionogi Eyes US Plant to Boost Antibiotic Production Amid Tariffs Challenge

Japan Forward

time3 hours ago

  • Japan Forward

Shionogi Eyes US Plant to Boost Antibiotic Production Amid Tariffs Challenge

このページを 日本語 で読む United States President Donald Trump has stated plans to gradually increase tariffs on pharmaceuticals to as high as 250%. In response, Shionogi & Company, Limited President Isao Teshirogi announced on August 7 that the firm is considering building a new manufacturing plant in the US. The facility would produce Cefiderocol (brand name Fetroja), a drug for treating Gram-negative bacterial infections, which is in high demand in the US. Teshirogi revealed the plan in an interview with The Sankei Shimbun , adding that the plant is expected to be completed by January 2029, while Trump is still in office. Cefiderocol is currently produced exclusively at Shionogi's factory in Kanegasaki Town, Iwate Prefecture. If the plan goes ahead, the new facility would mark the company's first pharmaceutical manufacturing plant in the US. The firm is already evaluating the supply chain for the raw materials needed for construction, as well as securing land and personnel for the project. US President Donald Trump speaks at the White House, July 31, Washington (©Reuters via Kyodo) "If relying entirely on overseas pharmaceutical supplies poses a national security threat, then I agree," Teshirogi said, showing an understanding of Trump's policy. "I believe it's reasonable to want to accelerate and vigorously promote [domestic manufacturing]." "The ultimate goal is to save patients. If President Trump says, 'I want this product to be made in the US,' then we need to consider building a factory to meet that demand," he added. "We are already developing concrete plans for construction so we can act swiftly in line with the administration's direction." Regarding financing the project, Teshirogi said, "We will also require subsidies from the US government to support the construction of the new plant." Shionogi Pharmaceutical Research Center in Toyonaka City, Osaka (©Sankei by Yuta Yasumoto) The drug Cefiderocol is effective against infections caused by multidrug-resistant bacteria, meaning bacteria that have developed resistance to many other antibiotics. It's currently sold in Japan, the United States, and Europe, with demand growing, especially in the US. Drawing lessons from the COVID-19 pandemic, the Japanese pharmaceutical maker emphasizes the importance of promoting local production overseas to mitigate supply chain risks. "We are planning to launch Cefiderocol in the US around 2030 or 2040. If we do so, building a factory [there] is unavoidable," the company president said. However, specialized facilities are required to produce the antibiotics that become the raw materials for Cefiderocol. Manufacturing these antibiotics is complex, and there seem to be few of these facilities in the US. Therefore, securing skilled engineers could be challenging. Furthermore, China holds a near-monopoly on the supply of active ingredients for the antibiotics, "making it even more difficult to produce them at fermentation plants in the US," Teshirogi noted. Shionogi's president acknowledged that transferring manufacturing technology and securing a stable supply of raw materials would be the biggest hurdles ahead. Author: Yohei Ushijima, Sarasa Shimizu (The Sankei Shimbun) このページを 日本語 で読む

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store